All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-LY1105 | Anti-GDF3 (1B9) h(41BB-CD3ζ) CAR, pCDCAR1 | 1B9 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY1106 | Anti-GDF3 (3C12) h(41BB-CD3ζ) CAR, pCDCAR1 | 3C12 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY1107 | Anti-GDF3 (4D7) h(41BB-CD3ζ) CAR, pCDCAR1 | 4D7 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY1108 | Anti-GDF3 (CBLG1-2693) h(41BB-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-2693 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-LY2745 | Anti-GDF3(1B9) h(CD28-CD3ζ) CAR, pCDCAR1 | 1B9 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY2746 | Anti-GDF3(3C12) h(CD28-CD3ζ) CAR, pCDCAR1 | 3C12 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY2747 | Anti-GDF3(4D7) h(CD28-CD3ζ) CAR, pCDCAR1 | 4D7 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | |||
CAR-LY2748 | Anti-GDF3(CBLG1-2693) h(CD28-CD3ζ) CAR, pCDCAR1 | Mouse, Rat, Human | CBLG1-2693 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION